Journal of Diseases and Medicinal Plants

Volume 7, Issue 2, June 2021

  • Antimicrobial Properties of the Hydroethanolic Extract of Bauhinia rufescens L. and Euphorbia hirta L., Two Plants of the Traditional Chadian Pharmacopoeia

    Emmanuel Issa, Adoum Fouda Abderrazzack, Kokou Anani, Ameyapoh Yaovi

    Issue: Volume 7, Issue 2, June 2021
    Pages: 30-34
    Received: Mar. 11, 2021
    Accepted: Mar. 23, 2021
    Published: Apr. 07, 2021
    Downloads:
    Views:
    Abstract: Objective: To evaluate the antimicrobial properties of hydroethanol extracts of Bauhinia rufescens L. and Euphorbia hirta L. Methodology and results: The hydroethanol extracts of Bauhinia rufescens L. and Euphorbia hirta L.; two plants of the Chadian traditional pharmacopoeia used in the treatment of infantile diarrhoea and gastroenteritis in adult... Show More
  • Assessment of Traditional Knowledge Associated with Medicinal Plants in North Achfer District, Amhara Region, North Ethiopia

    Tensay Ayalw, Edeget Merawi

    Issue: Volume 7, Issue 2, June 2021
    Pages: 35-43
    Received: Feb. 16, 2021
    Accepted: Jun. 17, 2021
    Published: Jun. 25, 2021
    Downloads:
    Views:
    Abstract: The objective of the study was to document traditional knowledge on medicinal plants in north Achefer district. This study was conducted using semi-structured interviews using purposeful and random sampling methods. The collected data was analyzed using IBM SPSS statics 21software. A total of 65 informants 59 male and 6 female were interviewed from... Show More
  • Extract from Cistus × Incanus L. Pandalis also Effective Against “British” Alpha (B.1.1.7) and “South African” Beta (B.1.351) SARS-CoV-2 Variants

    Jens-Martin Traeder

    Issue: Volume 7, Issue 2, June 2021
    Pages: 44-47
    Received: Jun. 17, 2021
    Accepted: Jun. 25, 2021
    Published: Jun. 30, 2021
    Downloads:
    Views:
    Abstract: Background: In previous studies, a special extract from Cistus × incanus L. Pandalis (Cystus Pandalis® extract) has already proven to be effective against SARS-CoV-2 in vitro. We assume that an effect was also likely against the new SARS-CoV-2 variants, like the “British” alpha variant (B.1.1.7) as well as against the “South African” beta variant (... Show More